Before Monday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the most important analyst commentary for investors.
UnitedHealth Group Boosted to “Buy”
UnitedHealth Group (UNH ) has been upgraded from “Hold” to “Buy” at Jefferies as the company may increase market share in fast growing areas. UNH has a dividend yield of 1.26%.
BMO Capital Upgrades AbbVie
AbbVie (ABBV ) has been upgraded from “Market Perform” to “Outperform” at BMO Capital on a valuation call. ABBV has a dividend yield of 3.29%.
Citi Raises Estimates on Walgreens Boots Alliance
Citigoup has raised its price target on Walgreens Boots Alliance (WBA ) to $107. This new price target suggests a 16% increase from the stock’s current price. The firm boosted estimates on WBA due to higher expected growth. WBA has a dividend yield of 1.47%.
St. Jude Medical Upgraded to “Neutral”
St. Jude Medical (STJ ) has been upgraded from “Underperform” to “Neutral” at Credit Suisse as its business is expected gain momentum in the next year. STJ has a dividend yield of 1.70%.
Freeport-McMoRan Upgraded at Citi
Freeport-McMoRan (FCX ) has been boosted to “Buy” at Citigroup as analysts expect the copper market to improve by 2016. FCX has a dividend yield of 1.09%.